PP
KIN

Paloma Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

Paloma Partners’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,200
Closed -$119K – 2073
2018
Q2 		$119K Buy
+11,200
New +$109K ﹤0.01% 1526
2015
Q3 		– Sell
-16,150
Closed -$110K – 2042
2015
Q2 		$110K Buy
+16,150
New +$115K ﹤0.01% 1668

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Paloma Partners's KIN Position: Q3 2018 in Review

Paloma Partners sold out of Kindred Biosciences, Inc. (KIN) in Q3 2018, closing a stake of 11,200 shares — an estimated $119K sold.

Paloma Partners first reported a position in KIN in Q2 2015 and held it in 2 quarters. The position peaked at $119K in Q2 2018. 81 funds tracked by Wall St. Rank hold KIN as of Q3 2018.

  • Paloma Partners reported no remaining Kindred Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
  • Paloma Partners sold 11,200 Kindred Biosciences, Inc. shares in Q3 2018, an estimated $119K.
  • Paloma Partners first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 2 quarters.
  • Paloma Partners's Kindred Biosciences, Inc. position peaked at $119K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2018.

Based on Paloma Partners's 13F filing for Q3 2018, filed 14 Nov 2018.